Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
J Hosp Infect. 2024 Apr 11:S0195-6701(24)00080-X. doi: 10.1016/j.jhin.2024.03.001. Online ahead of print.
J Hosp Infect. 2024.
PMID: 38609760
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, Porter RJ, Elumogo NT, Segal JP, Sharma N, Marsh B, Kontkowski G, Manzoor SE, Hart AL, Settle C, Keller JJ, Hawkey P, Iqbal TH, Goldenberg SD, Williams HRT.
Mullish BH, et al. Among authors: kontkowski g.
Gut. 2024 Apr 12:gutjnl-2023-331550. doi: 10.1136/gutjnl-2023-331550. Online ahead of print.
Gut. 2024.
PMID: 38609165
Item in Clipboard
Guidelines for the management of norovirus outbreaks in acute and community health and social care settings.
Chadwick PR, Trainor E, Marsden GL, Mills S, Chadwick C, O'Brien SJ, Evans CM, Mullender C, Strazds P, Turner S, Weston V, Toleman MS, de Barros C, Kontkowski G, Bak A.
Chadwick PR, et al. Among authors: kontkowski g.
J Hosp Infect. 2023 Jun;136:127-191. doi: 10.1016/j.jhin.2023.01.017. Epub 2023 Feb 15.
J Hosp Infect. 2023.
PMID: 36796728
No abstract available.
Item in Clipboard
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD.
Mullish BH, et al. Among authors: kontkowski g.
J Hosp Infect. 2018 Sep;100 Suppl 1:S1-S31. doi: 10.1016/j.jhin.2018.07.037.
J Hosp Infect. 2018.
PMID: 30173851
Free article.
No abstract available.
Item in Clipboard
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT.
Mullish BH, et al. Among authors: kontkowski g.
Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.
Gut. 2018.
PMID: 30154172
Free article.
Item in Clipboard
Cite
Cite